Double-blind, parallel, randomized, placebo-controlled 12-week efficacy and safety assessment of ZR-02-01 [fentanyl] in the treatment of chronic, moderate to severe osteoarthritis (OA) pain
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2012
At a glance
- Drugs Fentanyl (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors ZARS Pharma
- 04 Jun 2012 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 04 Jun 2012 Actual patient number is 202 according to ClinicalTrials.gov.
- 04 Jun 2012 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.